{"id":85121,"topic":"peptides","source":"动脉网","title":"长效多肽新药biotech：斩获融资数千万元 - 动脉网","url":"https://www.vbdata.cn/intelDetail/1100309","url_hash":"2dc5cb539a6107de60cbeefa197a31a780241171","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBwNE9YUDk1X1E2VG11X3dhWnBjVWNiLUpSQnVibnhuWGhNVG9vNUtZLVhVU3EybDFfenFuUk1qVWFVNVhiUUpPaGR0OFJFLTY2eS1R?oc=5\" target=\"_blank\">长效多肽新药biotech：斩获融资数千万元</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">动脉网</font>","content":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","image_url":"https://static-cdn.vcbeat.top/vbdata-ssr/pic/app-vb-logo.png","lang":"zh","published_at":"2026-09-18T05:10:00+00:00","fetched_at":"2026-09-18T09:15:12+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","cluster_id":null,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://www.vbdata.cn/intelDetail/1100309","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 197 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":197,"summary_length":197,"usable_text_length":197,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":197,"summary_length":197}},"news_item":{"id":85121,"canonical_url":"https://www.vbdata.cn/intelDetail/1100309","source_url":"https://www.vbdata.cn/intelDetail/1100309","title":"长效多肽新药biotech：斩获融资数千万元 - 动脉网","source_name":"动脉网","author":null,"published_at":"2026-09-18T05:10:00+00:00","locale":"zh","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBwNE9YUDk1X1E2VG11X3dhWnBjVWNiLUpSQnVibnhuWGhNVG9vNUtZLVhVU3EybDFfenFuUk1qVWFVNVhiUUpPaGR0OFJFLTY2eS1R?oc=5\" target=\"_blank\">长效多肽新药biotech：斩获融资数千万元</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">动脉网</font>","full_text":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","excerpt":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","extraction":{"state":"ok","confidence":0.75,"error":null,"explanation":"Medium confidence: short full text extraction produced 197 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.vbdata.cn/intelDetail/1100309","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 197 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":197,"summary_length":197,"usable_text_length":197,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":197,"summary_length":197}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"长效多肽新药biotech：斩获融资数千万元 - 动脉网","url":"https://www.vbdata.cn/intelDetail/1100309","summary":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","source":"动脉网","date":"2026-09-18T05:10:00+00:00","content":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","confidence":0.75,"diagnostics_url":"/api/diagnose?url=https%3A//www.vbdata.cn/intelDetail/1100309","quality_bucket":"medium","failure_kind":"none","retryable":false,"quality_reason":"Medium confidence: short full text extraction produced 197 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 197 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":197,"summary_length":197,"usable_text_length":197,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":197,"summary_length":197}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/85121","export_markdown":"/api/items/85121/export?format=markdown","export_json":"/api/items/85121/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.vbdata.cn/intelDetail/1100309"},"formats":{"full":{"id":85121,"title":"长效多肽新药biotech：斩获融资数千万元 - 动脉网","url":"https://www.vbdata.cn/intelDetail/1100309","source":"动脉网","author":null,"published_at":"2026-09-18T05:10:00+00:00","locale":"zh","topic":"peptides","tags":[],"excerpt":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","full_text":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","reading_time_min":1,"extraction":{"state":"ok","confidence":0.75,"error":null,"explanation":"Medium confidence: short full text extraction produced 197 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.vbdata.cn/intelDetail/1100309","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 197 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":197,"summary_length":197,"usable_text_length":197,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":197,"summary_length":197}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 197 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":197,"summary_length":197,"usable_text_length":197,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":197,"summary_length":197}},"actions":{"read":"/item/85121","export_markdown":"/api/items/85121/export?format=markdown","export_json":"/api/items/85121/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.vbdata.cn/intelDetail/1100309"}},"digest":{"id":85121,"title":"长效多肽新药biotech：斩获融资数千万元 - 动脉网","url":"https://www.vbdata.cn/intelDetail/1100309","source":"动脉网","topic":"peptides","published_at":"2026-09-18T05:10:00+00:00","excerpt":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","quality_bucket":"medium","quality_reason":"Medium confidence: short full text extraction produced 197 characters.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"长效多肽新药biotech：斩获融资数千万元 - 动脉网","subtitle":"动脉网 · 2026-09-18","summary":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","badges":["quality:medium"],"links":{"read":"/item/85121","original":"https://www.vbdata.cn/intelDetail/1100309","diagnose":"/api/diagnose?url=https%3A//www.vbdata.cn/intelDetail/1100309"},"quality_warning":null},"export":{"title":"长效多肽新药biotech：斩获融资数千万元 - 动脉网","url":"https://www.vbdata.cn/intelDetail/1100309","summary":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","source":"动脉网","date":"2026-09-18T05:10:00+00:00","content":"2026年9月，优利科（杭州）生物医药科技有限公司完成数千万人民币天使轮融资，由岚禾资本领投。本轮资金将重点投向依托核心技术平台的创新药管线研发、验证及临床申报，旨在全面加速公司长效蛋白多肽药物的研发进程和产业化落地。优利科由邹培建博士创立，深耕长效化蛋白多肽创新药研发，拥有自主知识产权的ZT技术平台，目前多款候选分子处于IND-enabling关键冲刺阶段。注：原文未提及具体财务顾问信息。","confidence":0.75,"diagnostics_url":"/api/diagnose?url=https%3A//www.vbdata.cn/intelDetail/1100309","quality_bucket":"medium","failure_kind":"none","retryable":false,"quality_reason":"Medium confidence: short full text extraction produced 197 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 197 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":197,"summary_length":197,"usable_text_length":197,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":197,"summary_length":197}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}